Latest Celgene Corp (CELG) Headlines 'Fast Mone
Post# of 119
Posted On: 03/13/2014 6:33:01 AM
Latest Celgene Corp (CELG) Headlines
'Fast Money' Recap: From Stocks to Bonds?
at The Street - 1 hr 32 mins ago
The trading panel discussed the S&P 500, copper and emerging markets.
Final Glance: Biotechnology companies
AP - Wed Mar 12, 5:02PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:
Midday Glance: Biotechnology companies
AP - Wed Mar 12, 12:28PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.:
Early Glance: Biotechnology companies
AP - Wed Mar 12, 9:31AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
Has Celgene Corporation Run Out of Steam in 2014?
Peter Stephens, The Motley Fool - Motley Fool - Sun Mar 09, 6:00AM CDT
Last year was a fantastic one for Celgene shareholders. Shares rose by 117% -- easily beating the S&P 500, which still managed to post a very respectable gain of just under 32%. Furthermore, Celgene was able to beat two of its biotechnology...
Watch for Shares of Celgene (CELG) to Approach Support at $149.77
Comtex SmarTrend(R) - Fri Mar 07, 9:35AM CST
Celgene (NASDAQ:CELG) has opened bearishly below the pivot of $159.20 today and has reached the first level of support at $153.19. Analysts will be watching for a cross of the next downside pivot targets of $149.77 and $140.34.
Stocks Open Higher, Turn Mixed After Employment Report
at Investor's Business Daily - Fri Mar 07, 9:31AM CST
Stocks opened higher Friday, then backtracked to mixed terrain as drugmakers and some leading stocks added drag in early trade. The Dow Jones industrial average remained ahead 0.4%. The S&P 500 was up 0.2% and the Nasdaq slipped 0.2%. Celgene (CELG),...
Celgene Set to Possibly Rebound After Yesterday's Selloff of 4.06%
Comtex SmarTrend(R) - Thu Mar 06, 4:02PM CST
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $155.78 to a high of $165.21. Yesterday, the shares fell 4.1%, which took the trading range below the 3-day low of $158.63 on volume of 5.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SmarTrend Watching for Potential Rebound in Shares of Celgene After 4.06% Loss
Comtex SmarTrend(R) - Thu Mar 06, 4:01PM CST
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $155.78 to a high of $165.21. Yesterday, the shares fell 4.1%, which took the trading range below the 3-day low of $158.63 on volume of 5.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Better Biotech Buy: Celgene vs. Gilead Sciences
Dan Carroll, The Motley Fool - Motley Fool - Thu Mar 06, 1:30PM CST
Big biotech stocks have been on a roll lately, and industry mainstays Celgene and Gilead Sciences are no exceptions. Each stock has gained more than 50% over the past year as these two companies surge behind older established cash cow drugs...
'Fast Money' Recap: From Stocks to Bonds?
at The Street - 1 hr 32 mins ago
The trading panel discussed the S&P 500, copper and emerging markets.
Final Glance: Biotechnology companies
AP - Wed Mar 12, 5:02PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:
Midday Glance: Biotechnology companies
AP - Wed Mar 12, 12:28PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.:
Early Glance: Biotechnology companies
AP - Wed Mar 12, 9:31AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
Has Celgene Corporation Run Out of Steam in 2014?
Peter Stephens, The Motley Fool - Motley Fool - Sun Mar 09, 6:00AM CDT
Last year was a fantastic one for Celgene shareholders. Shares rose by 117% -- easily beating the S&P 500, which still managed to post a very respectable gain of just under 32%. Furthermore, Celgene was able to beat two of its biotechnology...
Watch for Shares of Celgene (CELG) to Approach Support at $149.77
Comtex SmarTrend(R) - Fri Mar 07, 9:35AM CST
Celgene (NASDAQ:CELG) has opened bearishly below the pivot of $159.20 today and has reached the first level of support at $153.19. Analysts will be watching for a cross of the next downside pivot targets of $149.77 and $140.34.
Stocks Open Higher, Turn Mixed After Employment Report
at Investor's Business Daily - Fri Mar 07, 9:31AM CST
Stocks opened higher Friday, then backtracked to mixed terrain as drugmakers and some leading stocks added drag in early trade. The Dow Jones industrial average remained ahead 0.4%. The S&P 500 was up 0.2% and the Nasdaq slipped 0.2%. Celgene (CELG),...
Celgene Set to Possibly Rebound After Yesterday's Selloff of 4.06%
Comtex SmarTrend(R) - Thu Mar 06, 4:02PM CST
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $155.78 to a high of $165.21. Yesterday, the shares fell 4.1%, which took the trading range below the 3-day low of $158.63 on volume of 5.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SmarTrend Watching for Potential Rebound in Shares of Celgene After 4.06% Loss
Comtex SmarTrend(R) - Thu Mar 06, 4:01PM CST
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $155.78 to a high of $165.21. Yesterday, the shares fell 4.1%, which took the trading range below the 3-day low of $158.63 on volume of 5.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Better Biotech Buy: Celgene vs. Gilead Sciences
Dan Carroll, The Motley Fool - Motley Fool - Thu Mar 06, 1:30PM CST
Big biotech stocks have been on a roll lately, and industry mainstays Celgene and Gilead Sciences are no exceptions. Each stock has gained more than 50% over the past year as these two companies surge behind older established cash cow drugs...
(0)
(0)